Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Viking Therapeutics Inc shares valued at $10,089,164 were sold by ZANTE GREG on Oct 28 ’24. At $76.61 per share, ZANTE GREG sold 131,687 shares. The insider’s holdings dropped to 149,366 shares worth approximately $10.84 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, GREG ZANTE purchased 131,687 shares, netting a total of over 10,275,537 in proceeds.
Before that, Rouan Sarah Kathryn had sold 11,000 shares from its account. In a trade valued at $889,790, the Director traded Viking Therapeutics Inc shares for $80.89 each. Upon closing the transaction, the insider’s holdings decreased to 11,000 shares, worth approximately $0.0.
As published in their initiating research note from JP Morgan on September 11, 2024, Viking Therapeutics Inc [VKTX] has been an Overweight and the price target has been revised to $80. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late June. As of May 16, 2024, Raymond James has increased its “an Outperform” rating to a “Strong buy” for VKTX. Earlier on March 26, 2024, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for VKTX stock.
Analyzing VKTX Stock Performance
During the last five days, there has been a drop of approximately -0.93%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 289.79%. Shares of the company reached a 52-week high of $99.41 on 02/28/24 and a 52-week low of $17.23 on 01/03/24. A 50-day SMA is recorded $64.28, while a 200-day SMA reached $59.56. Nevertheless, trading volume fell to 3.4 million shares from 3.99 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 70.72, which, if violated, would cause prices to drop to 68.90. In the upper region, resistance lies at 74.21. The next price resistance is at 75.88. RSI (Relative Strength Index) is 58.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 4.15, which suggests the price will increase in the coming days. Percent R is at 42.31%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
